Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Dongli Yue,Daiqun Zhang,Xiaojuan Shi,Shasha Liu,Anqi Li,Dong Wang,Guohui Qin,Yu Ping,Yamin Qiao,Xinfeng Chen,Feng Wang,Renyin Chen,Song Zhao,Lidong Wang,Yi Zhang

DOI: https://doi.org/10.3389/fonc.2022.860158

IF: 4.7

2022-02-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00311.].

oncology

What problem does this paper attempt to address?

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway

Jida Guo,Shengqiang Zhang,Jun Wang,Pengfei Zhang,Tong Lu,Linyou Zhang

DOI: https://doi.org/10.3389/fonc.2022.970020

IF: 4.7

2022-07-05

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.833719.].

oncology
Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Xiaozhong Liao,Ying Gao,Jiahui Liu,Lan-Ting Tao,Dongmei Wang,Dan Xie,Sui‐Lin Mo

DOI: https://doi.org/10.3389/fonc.2021.670798

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.01756/full.].
Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

Huijuan Liu,Honglian Tao,Hongqi Wang,Yuyan Yang,Ru Yang,Xintong Dai,Xiujuan Ding,Haidong Wu,Shuang Chen,Tao Sun

DOI: https://doi.org/10.3389/fonc.2022.830506

IF: 4.7

2022-02-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.619317.].

oncology
Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma

Yun-Zhu Zeng,Yong-Qu Zhang,Jiong-Yu Chen,Li-Ying Zhang,Wen-Liang Gao,Xue-Qiong Lin,Shao-Min Huang,Fan Zhang,Xiao-Long Wei

DOI: https://doi.org/10.3389/fonc.2021.767805

IF: 4.7

2021-10-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.627713.].

oncology
Corrigendum: Anlotinib Combined with Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma

Jingzhen Shi,Ying-jie Zhang,Jin-zhi Wang,Jianbin Li,Zhenxiang Li

DOI: https://doi.org/10.3389/fonc.2020.583499

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00995.].
Correction: Cepharanthine Hydrochloride Reverses the Mdr1 (P-Glycoprotein)-mediated Esophageal Squamous Cell Carcinoma Cell Cisplatin Resistance Through JNK and P53 Signals

Pengjun Zhou,Rong Zhang,Ying Wang,Dandan Xu,Li Zhang,Jinhong Qin,Guifeng Su,Yue Feng,Hongce Chen,Siyuan You,Wen Rui,Huizhong Liu,Suhong Chen,Hongyuan Chen,Yifei Wang

DOI: https://doi.org/10.18632/oncotarget.27638

2021-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.22676.].
Corrigendum: LncRNA FOXP4-AS1 Promotes the Progression of Esophageal Squamous Cell Carcinoma by Interacting with MLL2/H3K4me3 to Upregulate FOXP4

Yunfeng Niu,Gaoyan Wang,Yan Li,Wei Guo,Yanli Guo,Zhiming Dong

DOI: https://doi.org/10.3389/fonc.2022.1041732

IF: 4.7

2022-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.773864.].
Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Huan Shi,Xin-Yu LI,Yao Chen,Xing Zhang,Yong Wu,Zi-Xuan Wang,Pan-Hong Chen,Hui-Qi Dai,Ji Feng,Sayantan Chatterjee,Zhong-Jie Li,Xiao-Wei Huang,Hong-Qiao Wei,Jigang Wang,Guo-Dong Lu,Jing Zhou

DOI: https://doi.org/10.3389/fphar.2020.640750

IF: 5.6

2021-02-08

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.534171.].

pharmacology & pharmacy
Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin

Yuzhu Di,Yanan Jiang,Xiuyun Shen,Jing Liu,Yang Gao,Huimin Cai,Xiaoli Sun,Dandan Ning,Bing Liu,Jiaji Lei,Shizhu Jin

DOI: https://doi.org/10.3389/fonc.2021.785363

IF: 4.7

2021-11-15

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.679348.].

oncology
Erratum: [Corrigendum] Chloroquine potentiates the anticancer effect of sunitinib on renal cell carcinoma by inhibiting autophagy and inducing apoptosis.

Man-Li Li,You-Zhi Xu,Wen-Jie Lu,Yong-Huai Li,Shi-Sheng Tan,Hong-Jun Lin,Tian-Ming Wu,Yan Li,Si-Ying Wang,Ying-Lan Zhao

DOI: https://doi.org/10.3892/ol.2024.14403

2024-01-01

Oncology Letters

Abstract:[This corrects the article DOI: 10.3892/ol.2017.7635.].
Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis

Ganping Wang,Yarong Dai,Kang Li,Maosheng Cheng,Gan Xiong,Xiaochen Wang,Shuang Chen,Zhi Chen,Jianwen Chen,Xiuyun Xu,Rong-song Ling,Liang Peng,Demeng Chen

DOI: https://doi.org/10.3389/fcell.2021.675417

IF: 5.5

2021-03-24

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.627706.].

cell biology,developmental biology
Corrigendum: CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma

Suna Zhou,Mingxin Zhang,Chao Zhou,Wei Wang,Haihua Yang,Wenguang Ye

DOI: https://doi.org/10.3389/fonc.2020.619438

IF: 4.7

2021-03-04

Frontiers in Oncology

Abstract:[This corrects the article .].

oncology
Corrigendum: Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis

Mianmian Liao,Caiwei Wang,Bowen Yang,Danping Huang,Yifeng Zheng,Shengqi Wang,Xuan Wang,Juping Zhang,Chunbian Tang,Zheng Xu,Yu He,Ruolin Huang,Fengxue Zhang,Zhiyu Wang,Neng Wang

DOI: https://doi.org/10.3389/fphar.2022.809565

IF: 5.6

2022-02-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.659297.].

pharmacology & pharmacy
Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Hongda Pan,Jingxin Pan,Shibo Song,Lei Ji,Hong Lv,Zhangru Yang

DOI: https://doi.org/10.3389/fonc.2021.670041

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00643.].
Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Qiuqiang Chen,Gang Jia,Xilin Zhang,Wenxue Ma

DOI: https://doi.org/10.3389/fimmu.2024.1376045

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1332057.].

immunology
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum: the Significance of Transarterial Chemo(embolization) Combined with Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review

Qiao Ke,Fuli Xin,Huipeng Fang,Yongyi Zeng,Lei Wang,Jingfeng Liu

DOI: https://doi.org/10.3389/fimmu.2022.952446

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.913464.].
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Xuan Wei,Juanjuan Shi,Qianhan Lin,Xiaoxue Ma,Yingxin Pang,Hongluan Mao,Rui Li,Wei Lu,Yu Wang,Peishu Liu

DOI: https://doi.org/10.3389/fonc.2021.742374

IF: 4.7

2021-09-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.642229.].

oncology
[Corrigendum] Dihydroartemisinin Suppresses Proliferation, Migration, the Wnt/β‑catenin Pathway and EMT Via TNKS in Gastric Cancer

Yanmei Ma,Peng Zhang,Qilong Zhang,Xiaofei Wang,Qiong Miao,Xiaolan Lyu,Bo Cui,Honghong Ma

DOI: https://doi.org/10.3892/ol.2021.13152

2021-01-01

Oncology Letters

Abstract:[This corrects the article DOI: 10.3892/ol.2021.12949.].

Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma

Corrigendum: Anlotinib Combined with Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma

Correction: Cepharanthine Hydrochloride Reverses the Mdr1 (P-Glycoprotein)-mediated Esophageal Squamous Cell Carcinoma Cell Cisplatin Resistance Through JNK and P53 Signals

Corrigendum: LncRNA FOXP4-AS1 Promotes the Progression of Esophageal Squamous Cell Carcinoma by Interacting with MLL2/H3K4me3 to Upregulate FOXP4

Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin

Erratum: [Corrigendum] Chloroquine potentiates the anticancer effect of sunitinib on renal cell carcinoma by inhibiting autophagy and inducing apoptosis.

Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis

Corrigendum: CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma

Corrigendum: Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis

Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum: the Significance of Transarterial Chemo(embolization) Combined with Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

[Corrigendum] Dihydroartemisinin Suppresses Proliferation, Migration, the Wnt/β‑catenin Pathway and EMT Via TNKS in Gastric Cancer